Drawing for BCN PEPTIDES

USPTO serial 79018927

BCN PEPTIDES

Reviewed by CopyMark Law Group

Reg. 3348698Status 404
Filing date
Status date
Registration date
Dec 4, 2007
Examiner
DUBOIS, MICHELLE
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BCN PEPTIDES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith Swedo

Keith Swedo Bingham Greenebaum Doll LLP10 W. Market St.Suite 2700Indianapolis, IN 46204

Goods and services

ClassDescriptionStatusFirst use
001CHEMICALS FOR USE IN INDUSTRY AND SCIENCESECTION 71 - CANCELLED—
005PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM, NAMELY, ENCEPHALITIS, EPILEPSY, ALZHEIMER'S, CEREBRAL PALSY, PARKINSON'S DISEASE; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF RESPIRATORY DISEASES, NAMELY, RESPIRATORY INFECTIONS, ASTHMA, BRONCHITIS, PNEUMONIA; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF EATING DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF MUSCULO-SKELETAL DISORDERS, NAMELY, CONNECTIVE TISSUE DISEASES, BONE DISEASES, SPINAL DISEASES, BACK PAIN, FRACTURES, SPRAINS, CARTILAGE INJURIES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF UROLOGICAL, UROGENITAL AND URINARY DISORDERS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DERMATOLOGICAL DISEASES, NAMELY, DERMATITIS, SKIN PIGMENTATION DISEASES, PSORIASIS, ECZEMA, ROSACEA, BLOTCHES; PHARMACEUTICAL PREPARATIONS, NAMELY, CYTOSTATIC AGENTS, HORMONES, DIAGNOSTIC AGENTS FOR MEDICAL PURPOSES, ANTI-INFECTIVE AGENTS, BLOOD CLOTTING AGENTS, BLOOD ANTICOAGULANT AGENTS, VETERINARY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES, NAMELY, SWINE DYSENTERY, BACTERIAL ENTERITIS, BLUECOMB, PNEUMONIA, RESPIRATORY INFECTIONS, EYE INFECTIONS, TOPICAL INFECTIONS; VETERINARY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PARASITES; VETERINARY PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NUTRITIONAL MUSCULAR DYSTROPHY; VETERINARY PREPARATIONS FOR ANIMALS AND POULTRY TO GIVE NEWBORN ANIMALS AND BIRDS A HEALTHY STARTSECTION 71 - CANCELLED—
042SCIENTIFIC AND TECHNICAL CONSULTING AND RESEARCH RELATING TO PHARMACEUTICALS; SCIENTIFIC AND TECHNICAL CONSULTING AND RESEARCH IN THE FIELD OF CHEMISTRY FOR MEDICAL PURPOSES; DESIGN OF NEW PRODUCT DEVELOPMENT AND BIOCHEMICAL RESEARCH AND ANALYSISSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 18, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
May 17, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 12, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 12, 2019INPCINVALIDATION PROCESSED—
Mar 6, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 6, 2018C71TCANCELLED SECTION 71—
Dec 4, 2016REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 17, 2015RNWLINTERNATIONAL REGISTRATION RENEWED—
Aug 14, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 28, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 6, 2013NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 6, 201371AGREGISTERED-SEC.71 ACCEPTED—
Sep 6, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 23, 201371AFREGISTERED-SEC.71 FILED—
Aug 23, 2013ES71TEAS SECTION 71 RECEIVED—
May 15, 2009FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 10, 2008ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 24, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2008FIMPFINAL DISPOSITION PROCESSED—
Mar 4, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 4, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 29, 2007NPUBNOTICE OF PUBLICATION—
Aug 14, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 14, 2007ALIEASSIGNED TO LIE—
Jun 28, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2007OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 14, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 14, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2007OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 7, 2007OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 14, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 30, 2006MAILPAPER RECEIVED—
Nov 16, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 15, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 15, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 15, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 29, 2006RFNTREFUSAL PROCESSED BY IB—
Jun 9, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 9, 2006RFRRREFUSAL PROCESSED BY MPU—
Jun 9, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 8, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2006DOCKASSIGNED TO EXAMINER—
Jan 6, 2006NWAPNEW APPLICATION ENTERED—
Jan 5, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance